Joseph Rubinfeld
Keine laufenden Positionen mehr
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| John Caloz | M | 72 | 17 Jahre | |
| John Weber | M | 74 | 14 Jahre | |
| Elise Brownell | M | - | 10 Jahre | |
| Felix Kratz | M | - | 10 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Steven Kriegsman | M | 82 | 20 Jahre | |
| Louis J. Ignarro | M | 83 | 20 Jahre | |
| Dennis Fenton | M | 72 | 27 Jahre | |
| Elliott L. Fineman | M | - |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | 20 Jahre |
| Cheryl Cohen | F | 58 | 1 Jahre | |
| Anita J. Chawla | M | 65 | 2 Jahre | |
| Eric Jay Selter | M | 66 | 2 Jahre | |
| Craig Eagle | M | 57 | 7 Jahre | |
| Max E. Link | M | 84 | 18 Jahre | |
| Iain Ross | M | 71 | 1 Jahre | |
| Ronald Spair | M | 58 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | 2 Jahre |
| James Manuso | M | 75 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | 10 Jahre |
| George B. Rathmann | M | - | - | |
| Daniel J. Levitt | M | 76 | 8 Jahre | |
| Earl Warren Brien | M | 64 | 5 Jahre | |
| David A. Lowe | M | 77 | 2 Jahre | |
| Benjamin S. Levin | M | 46 | 12 Jahre | |
| Pitch Johnson | M | 95 | - | |
| Richard L. Wennekamp | M | 80 | - | |
| Michael Molkentin | M | 69 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | 8 Jahre |
| Gregory R. Liberman | M | 51 | - | |
| Marvin R. Selter | M | 95 | 11 Jahre | |
| Rajesh Shrotriya | M | 79 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | 4 Jahre |
| W. Dorsey Stuart | M | - |
Cetus Corp.
| 2 Jahre |
| Peter Farley | M | - |
Cetus Corp.
| 14 Jahre |
| Behzad Khosrovi | M | 80 |
Cetus Corp.
| 14 Jahre |
| Thomas J. White | M | 78 |
Cetus Corp.
| 11 Jahre |
| Sanjeev Gurunath Redkar | M | 56 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | 13 Jahre |
| Douglas Scott Wieland | M | 64 | 12 Jahre | |
| David J. Haen | M | 45 | - | |
| Joseph Connell | M | 67 | 1 Jahre | |
| Audrey F. Jakubowski | M | 81 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | 9 Jahre |
| Charles Casamento | M | 78 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | 9 Jahre |
| Christopher A. Hadsall | M | 49 | - | |
| Shi-Chung Ng | M | 69 | - | |
| Shanta P. Chawla | M | 76 | 3 Jahre | |
| Herbert H. McDade | M | 97 | - | |
| Olivia Ware | F | 67 | 1 Jahre | |
| Kirk C. Peacock | M | 55 | 1 Jahre | |
| Jaisim Shah | M | 63 | - | |
| Luigi Lenaz | M | 83 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | 3 Jahre |
| Robert Emanuele | M | 69 | 14 Jahre | |
| Walter J. Lack | M | 76 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | 11 Jahre |
| Matthew Natalizio | M | 69 | 3 Jahre | |
| Bill Bowes | M | 97 | - | |
| Robert Farrell | M | 74 | 2 Jahre | |
| Thomas V. Girardi | M | 84 |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | 11 Jahre |
| Raymond C. Carnahan | M | - | - | |
| Mark A. Tepper | M | 49 | - | |
| David Scott Geyer | M | 65 | - | |
| David L. Snitman | M | 72 | - | |
| Gordon Binder | M | 88 | 18 Jahre | |
| Jack R. Barber | M | 68 | - | |
| Mitchell K. Fogelman | M | 72 | 1 Jahre | |
| Larry Alan May | M | 74 | 15 Jahre | |
| G. Kirk Raab | M | 88 | 4 Jahre | |
| Daniel Vapnek | M | 85 | 15 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 61 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Joseph Rubinfeld
- Persönliches Netzwerk
